MitsudaN., TamakiH., AminoN.Risk factors for developmental disorders in infants born to women with Graves disease.Obstet Gynecol1992; 80: 359–64.
2.
LutonD., Le GacI., VuillardE.Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring.J Clin Endocrinol Metab2005; 90: 6093–8.
3.
ChattawayJ.M., KlepserT.B.Propylthiouracil versus methimazole in treatment of Graves’ disease during pregnancy.Ann Pharmacother2007; 41: 1018–22.
4.
SaffordS.D., SkinnerM.A.Thyroid and parathyroid disease in children.Semin Pediatr Surg2006; 15: 85–91.
